Short QT in a cohort of 1.7 million persons: Prevalence, correlates, and prognosis

Annals of Noninvasive Electrocardiology

Volumn 19, Issue 5, 2014, Pages 490-500

  Iribarren, Carlos ^a   Round, Alfred D ^a   Peng, Jonathan A ^b   Lu, Meng ^a   Klatsky, Arthur L ^a   Zaroff, Jonathan G ^b   Holve, Taylor J ^b   Prasad, Amit ^b   Stang, Paul ^c  

^a DIVISION OF RESEARCH   (United States)

^b KAISER PERMANENTE   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BLACK PERSON; CHANNELOPATHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONFERENCE PAPER; ECG ABNORMALITY; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROGNOSIS; QT INTERVAL; QT PROLONGATION; REPRODUCIBILITY; SHORT QT SYNDROME; SUDDEN CARDIAC DEATH; ADOLESCENT; AGED; ARRHYTHMIAS, CARDIAC; CHILD; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; UNITED STATES; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; CALIFORNIA; CHILD; COHORT STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RISK FACTORS;

EID: 84907812383     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/anec.12157     Document Type: Conference Paper

References (35)

1. Gaita F, Giustetto C, Bianchi F, et al. Short QT syndrome: A familial cause of sudden death. Circulation 2003;108(8):965-970.
2. Gussak I, Brugada P, Brugada J, et al. Idiopathic short QT interval: A new clinical syndrome? Cardiology 2000;94(2):99-102.
3. Schimpf R, Wolpert C, Gaita F, et al. Short QT syndrome. Cardiovasc Res 2005;67(3):357-366.
4. Gollob MH, Redpath CJ, Roberts JD. The short QT syndrome: Proposed diagnostic criteria. J Am Coll Cardiol 2011;57(7):802-812.
5. Moriya M, Seto S, Yano K, et al. Two cases of short QT interval. Pacing Clin Electrophysiol 2007;30(12):1522-1526.
6. Sawicki S, Stadnicki W, Kusnierz J, et al. [Short QT syndrome-A case report]. Kardiol Pol 2008;66(3):307-312.
7. Villafane J, Young ML, Maury P, et al. Short QT syndrome in a pediatric patient. Pediatr Cardiol 2009;30(6):846-850.
8. Giustetto C, Schimpf R, Mazzanti A, et al. Long-term follow-up of patients with short QT syndrome. J Am Coll Cardiol 2011;58(6):587-595.
9. Anttonen O, Junttila MJ, Rissanen H, et al. Prevalence and prognostic significance of short QT interval in a middle-aged Finnish population. Circulation 2007;116(7):714-720.
10. Gallagher MM, Magliano G, Yap YG, et al. Distribution and prognostic significance of QT intervals in the lowest half centile in 12,012 apparently healthy persons. Am J Cardiol 2006;98(7):933-935.
11. Kobza R, Roos M, Niggli B, et al. Prevalence of long and short QT in a young population of 41,767 predominantly male Swiss conscripts. Heart Rhythm 2009;6(5):652-657.
12. Funada A, Hayashi K, Ino H, et al. Assessment of QT intervals and prevalence of short QT syndrome in Japan. Clin Cardiol 2008;31(6):270-274.
13. Miyamoto A, Hayashi H, Yoshino T, et al. Clinical and electrocardiographic characteristics of patients with short QT interval in a large hospital-based population. Heart Rhythm 2012;9(1):66-74.
14. Nierenberg DW, Ransil BJ. Q-aTc interval as a clinical indicator of hypercalcemia. Am J Cardiol 1979;44(2):243-248.
15. Holbrook M, Malik M, Shah RR, et al. Drug induced shortening of the QT/QTc interval: an emerging safety issue warranting further modelling and evaluation in drug research and development? J Pharmacol Toxicol Methods 2009; 59(1):21-28.
16. Malik M. Errors and misconceptions in ECG measurement used for the detection of drug induced QT interval prolongation. J Electrocardiol 2004;37(Suppl):25-33.
17. Villafane J, Atallah J, Gollob MH, et al. Long-term follow-up of a pediatric cohort with short QT syndrome. J Am Coll Cardiol 2013;61(11):1183-1191.
18. Krieger N. Overcoming the absence of socioeconomic data in medical records: Validation and application of a census-based methodology. Am J Public Health 1992;82(5):703-710.
19. Kligfield P, Hancock EW, Helfenbein ED, et al. Relation of QT interval measurements to evolving automated algorithms from differentmanufacturers of electrocardiographs. Am J Cardiol 2006;98(1):88-92.
20. Zhou SH, Helfenbein ED, Lindauer JM, et al. Philips QT interval measurement algorithms for diagnostic, ambulatory, and patient monitoring ECG applications. Ann Noninvasive Electrocardiol 2009;14(Suppl 1):S3-8.
21. Indik JH, Pearson EC, Fried K, et al. Bazett and Fridericia QT correction formulas interfere with measurement of drug-induced changes in QT interval. Heart Rhythm 2006;3(9):1003-1007.
22. Selby JV, Fireman BH, Lundstrom RJ, et al. Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization. N Engl J Med 1996;335(25):1888-1896.
23. Iribarren C, Darbinian J, Klatsky AL, et al. Cohort study of exposure to environmental tobacco smoke and risk of first ischemic stroke and transient ischemic attack. Neuroepidemiology 2004;23(1-2):38-44.
24. Iribarren C, Karter AJ, Go AS, et al. Glycemic control and heart failure among adult patients with diabetes. Circulation 2001;103(22):2668-2673.
25. Arellano MG, Petersen GR, Petitti DB, et al. The California Automated Mortality Linkage System (CAMLIS). Am J Public Health 1984;74(12):1324-1330.
26. Reinig MG, Engel TR. The shortage of short QT intervals. Chest 2007;132(1):246-249.
27. Cordeiro JM, Brugada R, Wu YS, et al. Modulation of I(Kr) inactivation by mutation N588K in KCNH2: A link to arrhythmogenesis in short QT syndrome. Cardiovasc Res 2005;67(3):498-509.
28. Hong K, Piper DR, Diaz-Valdecantos A, et al. De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc Res 2005;68(3):433-440.
29. Priori SG, Pandit SV, Rivolta I, et al. A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res 2005;96(7):800-807.
30. Shah RR, Bjerregaard P, Gussak I. Drug-induced QT interval shortening: An emerging component in integrated assessment of cardiac safety of drugs. J Electrocardiol 2010;43(5):386-389.
31. Wortsman J, Frank S. The QT interval in clinical hypercalcemia. Clin Cardiol 1981;4(2):87-90.
32. Bohora S, Namboodiri N, Tharakan J, et al. Dilated cardiomyopathy with short QT interval: Is it a new clinical entity? Pacing Clin Electrophysiol 2009;32(5):688-690.
33. Teh HS, Tan HJ, Loo CY, et al. Short QTc in epilepsy patients without cardiac symptoms. Med J Malaysia 2007;62(2):104-108.
34. Naschitz J, Fields M, Isseroff H, et al. Shortened QT interval: A distinctive feature of the dysautonomia of chronic fatigue syndrome. J Electrocardiol 2006;39(4):389-394.
35. Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of beta-agonists in patients with asthma and COPD: A meta-analysis. Chest 2004;125(6):2309-2321.